IGFBP-2 was identified as the major regulatory carrier in childhood leukemia and exhibited an inverse correlation with IGF-1 levels [59], suggesting that activation of IGF-1R signaling may confer ALL cells a survival advantage and influence induction of apoptosis. The gene discussed is IGFBP2; the disease is acute lymphoblastic leukemia.